GILD250516P92500
- 0.10
- -1.05-91.30%
Gilead Sciences Newsroom
Trump's Drug Price Cuts: Will They Work?
"Don't sell if prices don't drop!" Trump enforces a mandatory minimum drug price for developed countries, but a lawsuit battle may be "reenacted".
① An executive order signed on the 12th of October, USA time, requires that the payment price of pharmaceuticals in the USA be forcibly anchored to the lowest level of other developed countries within 30 days; ② There is strong opposition within the USA, and industry experts estimate that a legal battle is about to "replay"; ③ As the market-oriented USA begins to wield the big stick of administrative pricing, the underlying rules of the game for Innovative Drugs have quietly been rewritten.
Gilead Sciences Up Nearly 8%, on Track for Largest Percent Increase Since June 2024 -- Data Talk
The "Most-Favored-Nation Pricing" policy for Trump Medicine has been issued: benchmarked against developed countries, complete the Quote within 30 days.
① This policy aims to align prescription drug pricing in the USA with that of "Other developed countries". Trump has requested that the Quote be completed within 30 days; ② The scope of affected Pharmaceuticals is still unclear, and the White House has stated that the government will pay special attention to drugs that have the "largest price differences and highest spending"; ③ Trump had implemented a similar policy before the end of his last term, but it was blocked by the courts and ultimately fell through.
$GILD Stock Is up 6% Today. Here's What We See in Our Data.
Roche Plans $700M North Carolina Facility
The Zacks Analyst Blog Highlights Disney, Gilead Sciences, Eaton and Maui Land & Pineapple
Innovation, Pharma Profits Won't Suffer Under Trump Prescription Drug EO - White House
Express News | Shares of U.S. Pharma Companies Reverse Premarket Course
Express News | Trump: Drug Prices to Be Cut by 59%, Plus Gasoline, Energy, Groceries, and All Other Costs, Down
Express News | Pfizer Down 2.8%, Eli Lilly Down 2.9%, Merck Down 1.1%, Gilead Sciences Down 3.2%, Johnson & Johnson Down 2.1%
Express News | Shares of U.S. Pharma Companies Fall Premarket as Trump to Sign Executive Order to Cut Prices of Medicine
Trump Renews Push for Most-Favored-Nation Drug Pricing. What It All Means
Trump plans to promote a "Global minimum price" drug reform order, which could reduce U.S. drug prices by up to 80%.
Trump plans to sign an executive order to lower the cost of pharmaceuticals in the USA, ensuring that Americans do not pay more for drugs than the lowest-priced country.
Trump Says Prescription Drug Prices Set To Drop By 30% To 80% 'Almost Immediately' Thanks To 'Most Favored Nation' Plan, Mark Cuban Urges President To 'Force Transparency'
Trump Says He'll Sign Executive Order to Lower Prescription-drug Prices
Is Gilead Sciences (GILD) Among the Best Stocks to Buy According to Jim Simons' Renaissance Technologies?
Top Analyst Reports for Walt Disney, Gilead Sciences & Eaton
Express News | Gilead Sciences Inc - Stockholders Reject Dei Practices Risk Report Proposal for Contractors - SEC Filing
FDA to Speed up AI Rollout to Accelerate Drug Reviews